Back to Archived Journals » Research and Reports in Biochemistry » Volume 3

A novel G-protein-coupled receptor-signaling platform and its targeted translation in human disease

Authors Abdulkhalek S, Hrynyk, Szewczuk M

Received 3 October 2012

Accepted for publication 24 October 2012

Published 7 January 2013 Volume 2013:3 Pages 17—30

DOI https://doi.org/10.2147/RRBC.S28430

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Video abstract presented by Professor Szewczuk

Views: 471

Samar Abdulkhalek,1 Michael Hrynyk,2 Myron R Szewczuk1

1Departments of Biomedical and Molecular Sciences, 2Chemical Engineering, Queen's University, Kingston, ON, Canada

Abstract: Molecular-targeted G-protein-coupled receptor (GPCR) signaling in human disease has become an important area of scientific and medical research. The interactions between GPCRs with their large number of different G-protein subunits and the large number of glycosylated receptors involved in human diseases are quite diverse. One GPCR is capable of interacting with more than one G protein to initiate multifunctional signaling. However, the activation of a number of GPCRs does not always lead to a direct effect alone on a particular signaling pathway, but rather to an amplification of the response produced by a separate circumstantial signal within the cell. This cross talk among different GPCR transduction signals is a focus of intense research. In this review, evidence exposing the invisible link connecting ligand-binding and receptor activation to a novel GPCR-signaling platform will be reviewed in relation to human disease.

Keywords: G-protein-coupled receptors, toll-like receptors, receptor tyrosine kinase, glycosylation, Neu1 sialidase, matrix metalloproteinase 9

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]